OptimizeRx Corporation
OPRX
$7.77
$0.628.67%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -218.46% | 3.65% | -7.83% | -1,171.15% | 17.36% |
| Total Depreciation and Amortization | 139.95% | 139.95% | 139.42% | 61.57% | 59.97% |
| Total Amortization of Deferred Charges | 470.83% | 438.30% | 427.08% | 126.76% | -81.14% |
| Total Other Non-Cash Items | 145.78% | -19.70% | -30.01% | 159.90% | -20.09% |
| Change in Net Operating Assets | 174.24% | 127.68% | 244.44% | -722.46% | -79.69% |
| Cash from Operations | 21.59% | 133.01% | 2,562.79% | -323.19% | -57.45% |
| Capital Expenditure | 45.45% | -125.00% | -10.34% | 67.48% | -41.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 92.43% | -101.23% | 92.04% | 394.57% | 97.39% |
| Cash from Investing | 90.89% | -102.64% | 90.13% | -40.66% | 97.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -35.90% | -99.54% |
| Repurchase of Common Stock | 34.69% | 94.54% | 18.13% | 98.05% | 99.60% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -52.87% | 87.78% | -388.55% | 586.46% | 97.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 906.03% | 96.71% | 174.99% | 117.00% | 100.25% |
